Skip to main content
Smart Investors Daily
PT

AMEX · PTN

Palatin Technologies, Inc.

Healthcare · Biotechnology

$12.70

Down-$0.38 (-2.91%)

Updated Sep 8, 2026, 5:28 AM

SID Score

4.9/10

Composite research score

Smart Money

Institutional and insider signal

Market cap
641.56M
P/E ratio
-4.99
Dividend yield
0.00%
52-week range
$7.21 – $23.78
Volume
257.72K
Avg. volume
1.78M

Price performance

PTN price history

1M range · 20 trading sessions · Daily adjusted prices

PTN closed at $12.70 after 20 trading sessions, up 72.55% for the selected period.

Last close
$12.70
Period change
+72.55%
Period low
$7.36
Period high
$13.08
Daily close
View OHLC price history
PTN OHLC price history, latest 40 sessions
DateOpenHighLowCloseVolume
Sep 4, 2026$12.83$13.48$12.49$12.70257.72K
Sep 3, 2026$12.82$14.00$12.34$13.08534.54K
Sep 2, 2026$12.00$13.50$11.29$12.84311.13K
Sep 1, 2026$9.63$11.82$9.175$11.54149.15K
Aug 31, 2026$10.52$10.73$9.42$9.99153.25K
Aug 28, 2026$10.5596$11.11$9.65$10.48129.11K
Aug 27, 2026$10.09$10.49$9.55$10.4962.19K
Aug 26, 2026$10.60$10.9299$9.26$10.4758.52K
Aug 25, 2026$10.35$10.92$9.88$10.37106.83K
Aug 24, 2026$9.69$10.16$9.69$10.161.79K
Aug 21, 2026$10.63$10.7493$9.69$9.694.5K
Aug 20, 2026$10.99$10.99$10.15$10.207.49K
Aug 19, 2026$10.40$10.9668$10.13$10.188.79K
Aug 18, 2026$10.66$11.13$10.27$10.5122.45K
Aug 17, 2026$9.61$10.38$9.50$9.9511.85K
Aug 14, 2026$10.27$10.27$8.8091$9.3612.33K
Aug 13, 2026$9.50$10.93$9.50$10.0044.4K
Aug 12, 2026$7.6274$9.58$7.2701$9.47180.24K
Aug 11, 2026$7.74$7.74$7.3701$7.416.92K
Aug 10, 2026$7.76$8.20$7.28$7.3612.81K

Latest PTN news

The latest Smart Investors Daily articles mentioning PTN.

PTN research

Overview

Company profile and research snapshot.

Company profile

Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.

Visit company website

Analyst outlook

Consensus and target data currently published for this company.

Consensus
Buy
Average target
$50.00
Implied upside
Analysts
5
PTN recent ratings
DateFirmRatingTarget
Dec 12, 2025Laidlaw & Co.Buy
Feb 13, 2025HC Wainwright & Co.Buy
Feb 7, 2025HC Wainwright & Co.Buy
Jan 29, 2025HC Wainwright & Co.Buy
Jan 28, 2025HC Wainwright & Co.Buy
Open full forecast

News briefing

No generated briefing is available yet.

247wallst.com · Dec 3, 2025

Here Are Wednesday’s Top Wall Street Analyst Upgrades and Downgrades: American Eagle Outfitters, Equinix, Garmin, Honeywell, Uber, Wendy’s and More

Pre-Market Stock Futures: The futures are trading higher on Wednesday after a stellar day across Wall Street on Tuesday. All of the major indices finished the day higher, with the technology-heavy NASDAQ leading the way, closing up 0.59% at 23,413. The S&P 500 ended the session at 6,829, up 0.25% and the Dow Jones Industrials... Here Are Wednesday's Top Wall Street Analyst Upgrades and Downgrades: American Eagle Outfitters, Equinix, Garmin, Honeywell, Uber, Wendy's and More.

AI research layers

Interpretive context generated from the platform’s current data sources.

No results

AI research layers have not been published yet.